• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Six New Members Added to MHE Editorial Advisory Board

Publication
Article
MHE PublicationMHE October 2020
Volume 30
Issue 10

Francois de Brantes, Otis Brawley, Eric C. Hunter, Keely Macmillan, Ateev Mehrotra, and Marc Samuels are joining the Managed Healthcare Executive® editorial advisory board.

We are looking forward to working with six new members of the Managed Healthcare Executive® editorial advisory board.

François de Brantes, M.S., MBA

Francois de Brantes

Francois de Brantes

François de Brantes is the senior vice president of episodes of care at Signify Health. He leads customer development of the Medicare Advantage, self-insured employer, and commercial payer markets. He has spent close to two decades working to transform the U.S. healthcare system by improving incentives for providers and consumers in order to encourage value-based decisions.

Prior to joining Signify Health, de Brantes served as vice president of Altarum, a national nonprofit. From 2006 to 2016, he was executive director of the Health Care Incentives Improvement Institute, a not-for-profit company that designed programs to motivate physicians and hospitals to improve the quality and affordability of healthcare delivery. The organization was responsible for the Bridges to Excellence® (BTE) and PROMETHEUS Payment® programs, which compensate and reward clinicians that focus on episodes of care and performance measures.

Prior to HCI3, François was chief operating officer of the eHealth Initiative (eHI). Early in his career he worked in General Electric’s corporate health care department.

De Brantes holds a master’s degree in economics and finance from the University of Paris IX-Dauphine and earned an MBA from the Tuck School of Business Administration at Dartmouth College. He lives in northwestern Connecticut.

Otis Brawley, M.D.

Otis Brawley

Otis Brawley

Otis Brawley is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University in Baltimore and a globally recognized expert on cancer prevention and control and health disparities. Prior to Johns Hopkins, Brawley was chief medical and scientific officer and executive vice president of the American Cancer Society from 2007 to 2018. From 2001 to 2007, he was medical director of the Georgia Cancer for Excellence at Grady Memorial Hospital in Atlanta and deputy director for cancer control at the Winship Cancer Institute at Emory University, also in Atlanta.

Brawley is author of How We Do Harm: A Doctor Breaks Ranks About Being Sick in America and has been an outspoken critic of overscreening for medical conditions, especially cancer.

Brawley is member of the National Academy of Medicine and board certified in internal medicine and medical oncology. He has served on many committees and advisory panels.

Brawley earned his medical degree from the University of Chicago’s Pritzker School of Medicine and did his residency at University Hospitals of Cleveland, Case Western Reserve University before completing a fellowship at the National Cancer Institute.

Eric C. Hunter, MBA

Eric C. Hunter

Eric C. Hunter

Eric Hunter is the president and CEO fo CareOregon, a nonprofit health plan based in Portland, Oregon, that serves more than 375,000 Medicaid and Medicare beneficiaries. Prior to CareOregon, Hunter was the chief operating officer for the Boston Medical Center Healthnet/Well Sense Health Plan in Boston.

He has also held executive positions at Beacon Health Options (previously known as ValueOptions), Centene, Schaller Anderson, and the State of Oklahoma.

Hunter earned his MBA from Northeastern University in Boston. He lives in Portland, Oregon.

Keely Macmillan, M.S.

Keely Macmillan

Keely Macmillan

Keely Macmillan is senior vice president of policy and solutions management at Archway Health, a value-based care solutions company headquartered in Boston. Macmillan leads a team of healthcare policy experts who evaluate two-sided risk models with a focus on technical and programmatic risk for the purposes of enhanced stop loss underwriting and helping participating providers succeed.

Prior to Archway Health, Macmillan was manager of government payment policy at Partners Healthcare in Boston where she managed public payer financial forecasting and led the analysis of performance-based payment models. Earlier in her career, she worked as a research analyst at Business Intelligence Advisors and at Yale University.

Macmillan earned a masters of science in public health from the Harvard T.H. Chan School of Public Health. She lives in Boston.

Ateev Mehrotra, M.D., M.P.H.

Ateev Mehrotra

Ateev Mehrotra

Ateev Mehrotra is an associate professor in the Department of Health Care Policy at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center in Boston. Much of Mehrotra’s research has focused on innovations in delivery such as telemedicine, retail clinics and e-visits have on quality, costs, and access to health care. He is also interested in the role of consumerism and whether price transparency and public reporting of quality can impact patient decision making. Another research interest is quality measurement including how natural language processing can be used to analyze the data in electronic health records to measure the quality of care.

Mehrotra has served on many committees and has been a RAND Corporation analyst since 2006.

Mehrotra earned his medical degree from University of California, San Francisco; a masters in public health from University of California, Berkeley; and masters of science degree from Harvard. He did a combined medicine-pediatrics residency at Massachusetts General Hospital and Boston Children’s Hospital. He lives in the Boston area.

Marc Samuels, J.D, M.P.H.

Marc Samuels

Marc Samuels

Marc Samuels is the CEO of ADVI, a Washington, D.C.-based based advisory services firm whose strategies, policy analysis and data products help clients and organizations across the life sciences.

Prior to ADVI and its predecessor HillCo HEALTH, Samuels served both former Presidents George H.W. Bush and George W. Bush in federal and state government, respectively.

Samuels started his consulting career as a partner in the Health Policy Group, a firm founded by J. Michael Hudson, who served President George H.W. Bush in the Health Care Financing Administration (the predecessor to CMS) and President Ronald Reagan in the Treasury department and at the White House.

Samuels is policy counsel to the National Comprehensive Cancer Network and is a founding board member of the University of California, San Francisco, Roseman Institute’s BUILD Program

Samuels earned his law degree from the University of Texas Law School and his M.P.H. from Yale School of Medicine. He lives in Washington, D.C., and Austin, Texas.

Related Videos
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Related Content
© 2024 MJH Life Sciences

All rights reserved.